CEBINA has partnered with Evotec, the industry-leading drug discovery and development company, to create Danube Labs, an initiative to accelerate academic research projects for new therapeutics to mature into projects ready for spin-out company formation, or out-licensing. We provide funding to bridge the gap between academia and industry, translating academic research projects into focused drug discovery programs.
WHAT ARE WE LOOKING FOR
- Innovative drug discovery projects from Universities and Research Institutes in Central and Eastern Europe (stage of development: at least in vitro PoC, ideally in vivo PoC)
- Projects with significant commercial potential and unmet medical need
- Intellectual Property (either filed patents or potential for new IP)
- Collaborative team spirit
HOW IT WORKS
Submit a 1-3 page overview of your project to us
We will evaluate your project and for selected projects work with you to create a detailed acceleration project proposal
Project proposals will be reviewed by our Joint Steering Committee for Danube Labs awards (ca. 500k€)
For awarded projects research work will be carried out by you, Evotec and CEBINA to reach the planned milestones within 6 to 9 months
Projects that meet the defined milestones and success criteria will be commercialized either through spin-out company formation or out-licencing
Submit your project by May 8, 2022 at https://www.danubelabs.eu/applications
Information on the call: https://www.cebina.eu/call4proposals